GPCRs as Emerging ADC Drug Candidates - BioProcess InternationalBioProcess International
Antibody drug conjugates – The time is now | pharmaphorum
Teva Itunda Performance Sandal | ADC Footwear
Ambrx Biopharma Stops Working On Breast Cancer Candidate, Cites Competition As The Reason
NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells - ScienceDirect